Detalhe da pesquisa
1.
A guiding map for inflammation.
Nat Immunol
; 18(8): 826-831, 2017 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28722720
2.
Author Correction: A guiding map for inflammation.
Nat Immunol
; 22(2): 254, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33288963
3.
Visceral Adiposity and Progression of ADPKD: A Cohort Study of Patients From the TEMPO 3:4 Trial.
Am J Kidney Dis
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38608748
4.
Kidney Energetics and Cyst Burden in Autosomal Dominant Polycystic Kidney Disease: A Pilot Study.
Am J Kidney Dis
; 2024 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38621633
5.
Sodium Bicarbonate Treatment and Vascular Function in CKD: A Randomized, Double-Blind, Placebo-Controlled Trial.
J Am Soc Nephrol
; 34(8): 1433-1444, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37228030
6.
Time-efficient, high-resistance inspiratory muscle strength training increases cerebrovascular reactivity in midlife and older adults.
Am J Physiol Heart Circ Physiol
; 325(5): H1059-H1068, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37682232
7.
Sources of Clinician Burnout in Providing Care for Underserved Patients in a Safety-Net Healthcare System.
J Gen Intern Med
; 38(6): 1468-1475, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36376633
8.
Cerebrovascular Pulsatility Index Is Reduced in Autosomal Dominant Polycystic Kidney Disease.
Am J Nephrol
; 54(5-6): 165-174, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37231790
9.
NAD+-boosting compounds enhance nitric oxide production and prevent oxidative stress in endothelial cells exposed to plasma from patients with COVID-19.
Nitric Oxide
; 140-141: 1-7, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37657532
10.
Metabolic reprogramming in a slowly developing orthologous model of polycystic kidney disease.
Am J Physiol Renal Physiol
; 322(3): F258-F267, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35037466
11.
Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study.
Am J Kidney Dis
; 79(4): 518-526, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34391872
12.
Endocannabinoid System in Polycystic Kidney Disease.
Am J Nephrol
; 53(4): 264-272, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35263737
13.
Kidney tubule health, mineral metabolism and adverse events in persons with CKD in SPRINT.
Nephrol Dial Transplant
; 37(9): 1637-1646, 2022 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34473302
14.
Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
J Am Soc Nephrol
; 32(1): 211-222, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33272965
15.
Mineral bone disease in autosomal dominant polycystic kidney disease.
Kidney Int
; 99(4): 977-985, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32926884
16.
Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop.
Am J Kidney Dis
; 77(2): 255-263, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32771648
17.
Chronic kidney disease, atherosclerotic plaque characteristics on carotid magnetic resonance imaging, and cardiovascular outcomes.
BMC Nephrol
; 22(1): 69, 2021 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33627066
18.
Patient Navigation: Addressing Social Challenges in Dialysis Patients.
Am J Kidney Dis
; 76(1): 121-129, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515136
19.
Core Outcome Domains for Trials in Autosomal Dominant Polycystic Kidney Disease: An International Delphi Survey.
Am J Kidney Dis
; 76(3): 361-373, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32359822
20.
Predictors of Hyperkalemia and Hypokalemia in Individuals with Diabetes: a Classification and Regression Tree Analysis.
J Gen Intern Med
; 35(8): 2321-2328, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32301044